Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA

Fig. 2

m6A demethylase FTO significantly increased in PD models in vitro and in vivo. A Heatmap of the m6A-related genes in the striatum of 6 cases of PD patients and 6 cases of healthy persons from GSE54282 datasets. B qRT-PCR analysis of m6A-related genes in the striatum of mice PD model (n = 3). C Western blotting analysis of the indicated protein expressions in the striatum of mice PD model. D IHC analysis of FTO in the striatum of mice PD model (n = 3). E qRT-PCR analysis of m6A-related genes in the cellular PD model (n = 3). F Western blotting analysis of the indicated protein expressions in the cellular PD model. G Immunofluorescence staining analysis of FTO expressions in the cellular PD model (n = 3). Data are represented as mean ± SD, *represents P < 0.05, **represents P < 0.01

Back to article page